Towards psychedelic apprenticeship: Developing a gentle touch for the mediation and validation of psychedelic-induced insights and revelations

Psychedelics alter metaphysical beliefs

(2021) Christopher Timmermann et al.   Scientific Reports

Psychedelics as Tools for Belief Transmission. Set, Setting, Suggestibility, and Persuasion in the Ritual Use of Hallucinogens

(2021) David Dupuis   Frontiers in Psychology

Emotions and brain function are altered up to one month after a single high dose of psilocybin

(2020) Frederick S. Barrett et al.   Scientific Reports

Psychedelic Psychiatry’s Brave New World

(2020) David Nutt et al.   CELL

Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory

(2019) Leor Roseman et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Neural correlates of the DMT experience assessed with multivariate EEG

(2019) Christopher Timmermann et al.   Scientific Reports

Psychedelics and the essential importance of context

(2018) Robin L Carhart-Harris et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Psychedelics Promote Structural and Functional Neural Plasticity

(2018) Calvin Ly et al.   Cell Reports

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression

(2018) Leor Roseman et al.   Frontiers in Pharmacology

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up

(2017) R. L. Carhart-Harris et al.   PSYCHOPHARMACOLOGY

Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI)

(2016) Matthew M. Nour et al.   Frontiers in Human Neuroscience

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

(2016) Roland R Griffiths et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Neural correlates of the LSD experience revealed by multimodal neuroimaging

(2016) Robin L. Carhart-Harris et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans

(2015) José Carlos Bouso et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

LSD enhances suggestibility in healthy volunteers

(2014) R. L. Carhart-Harris et al.   PSYCHOPHARMACOLOGY

Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestion

(2011) Draulio B. de Araujo et al.   HUMAN BRAIN MAPPING

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

(2011) Roland R. Griffiths et al.   PSYCHOPHARMACOLOGY

Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)

(2010) Erich Studerus et al.   PLoS One

Human hallucinogen research: guidelines for safety

(2008) MW Johnson et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

(2008) RR Griffiths et al.   JOURNAL OF PSYCHOPHARMACOLOGY